| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 95913 |
|
2,145 |
2,067 |
$342K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,506 |
1,500 |
$279K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,601 |
1,591 |
$269K |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,007 |
1,004 |
$164K |
| 93976 |
|
1,910 |
1,888 |
$157K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,662 |
1,656 |
$149K |
| 95886 |
|
1,248 |
1,204 |
$129K |
| 76770 |
|
2,077 |
2,069 |
$116K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,791 |
1,784 |
$112K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
578 |
570 |
$99K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
158 |
158 |
$49K |
| 76536 |
|
338 |
335 |
$19K |
| 95811 |
|
57 |
57 |
$18K |
| 93016 |
|
1,726 |
1,721 |
$18K |
| 93017 |
|
1,342 |
1,338 |
$8K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
571 |
389 |
$6K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
212 |
124 |
$4K |
| 76377 |
|
100 |
93 |
$3K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
107 |
104 |
$3K |
| 93880 |
|
25 |
25 |
$3K |
| 71271 |
|
60 |
60 |
$2K |
| 76830 |
Ultrasound, transvaginal |
79 |
79 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
14 |
13 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
54 |
54 |
$1K |
| 76881 |
|
13 |
13 |
$550.69 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
20 |
20 |
$448.28 |